U.S. Building Stock News

Latest FY 2025 earnings snapshot Atlas Energy Solutions (AESI) has just posted FY 2025 numbers that put the recent reset in profitability front and center, with Q4 revenue at US$249.43 million and a basic EPS loss of US$0.18, alongside trailing 12 month revenue of about US$1.10 billion and a basic EPS loss of US$0.41. Over the last six reported quarters, the company has seen quarterly revenue move between US$259.61 million and US$304.43 million while basic EPS has swung from a profit of...

Investors may be wondering whether Alcoa at around US$61.41 a share is offering good value today, or if the easy gains are already behind it. The stock has returned 6.9% over the last 7 days, is roughly flat over 30 days with a 1.3% decline, and is showing gains of 8.6% year to date and 81.0% over the last year. This naturally raises questions about how the market is now pricing its risks and opportunities. Recent coverage of Alcoa has focused on its role as a major aluminum producer, with...

Frontier Group Holdings (ULCC) has drawn fresh attention after filing a US$12.25 million shelf registration for 2,290,108 common shares tied to an ESOP offering, shortly after reporting a full year 2025 net loss. See our latest analysis for Frontier Group Holdings. The share price has moved sharply around these updates, with a 1-day share price return of a 4.92% decline and a 7-day share price return of a 13.27% decline. Over a longer period, the 90-day share price return is a 4.5% gain,...

In the past quarter, Gladstone Land Corporation reported fourth-quarter 2025 sales of US$41.45 million and net income of US$4.21 million, alongside full-year 2025 revenue of US$88.34 million and net income of US$13.53 million. The sharp year-over-year improvement in quarterly sales and earnings contrasts with softer full-year sales, highlighting how recent operational performance may be shifting for this farmland-focused REIT. Next, we’ll consider how this strong quarterly earnings growth,...

Recent performance snapshot Bel Fuse (BELF.A) has drawn fresh attention after a strong recent run, with the share price showing a 19% gain over the past month and a 67% move in the past 3 months. See our latest analysis for Bel Fuse. The recent momentum is building rather than fading, with a 30 day share price return of 19.2% and a 90 day share price return of 67%, alongside a 1 year total shareholder return of 161.2%. If Bel Fuse’s run has you thinking about where else strong trends might...

Moomoo, operated by Futu Holdings (NasdaqGM:FUTU), partnered with a financial education non profit to run a national student stock trading competition. The competition awards significant funding to the winning school to support financial literacy programs. The initiative is aimed at engaging students and promoting practical investing education across campuses. Futu Holdings, through its Moomoo platform, focuses on online brokerage and investing tools for retail clients. This new education...

Leonardo DRS (DRS) just closed out FY 2025 with fourth quarter revenue of US$1.1b and basic EPS of US$0.39, capped by trailing twelve month revenue of US$3.6b and EPS of US$1.05 as profit growth outpaced the company’s five year trend. The business has seen revenue move from US$981 million in Q4 2024 to US$1.1b in Q4 2025, while quarterly EPS shifted from US$0.34 to US$0.39 over the same period, against a backdrop of 30.5% earnings growth over the last year and a net margin that improved from...

Paymentus Holdings (PAY) has wrapped up FY 2025 with Q4 revenue of US$330.5 million and basic EPS of US$0.16, while trailing twelve month revenue reached US$1.2 billion and EPS came in at US$0.53. The company has seen quarterly revenue move from US$257.9 million in Q4 2024 to US$330.5 million in Q4 2025, with basic EPS over that span ranging from US$0.11 to US$0.16, and trailing net profit margin running at 5.6%. For investors, that combination of higher revenue scale, expanding EPS and a...

If you are wondering whether CMS Energy's current share price offers fair value or a potential opportunity, looking beyond the headline number can help you build a clearer view. With CMS Energy recently closing at US$76.78 and returns of 1.0% over 7 days, 8.6% over 30 days, 9.0% year to date, 8.2% over 1 year, 43.2% over 3 years, and 63.0% over 5 years, many investors are reassessing what they are paying for the stock today. Recent coverage has focused on CMS Energy as a regulated utilities...

Digital Turbine, Inc. recently appointed Ben John, a veteran ad-tech and AI leader formerly at Microsoft and Xandr, as Chief Technology Officer to oversee global engineering, product architecture, data-centric scaling, and AI-driven development. This move comes alongside strong year-over-year revenue and EBITDA growth linked to international expansion and AI integration, highlighting management’s focus on turning technical capabilities into operational efficiency and business outcomes. We’ll...

Hims & Hers Health (HIMS) has capped FY 2025 with fourth quarter revenue of US$617.8 million and basic EPS of US$0.09, rounding out a year in which its trailing twelve month revenue reached about US$2.3 billion and basic EPS came in at roughly US$0.57. Over recent periods the company has seen revenue move from US$481.1 million in Q4 2024 to US$617.8 million in Q4 2025, while quarterly basic EPS shifted from US$0.12 a year ago to US$0.09 most recently. This has set up a results season where...

Ally Financial (NYSE:ALLY) approved a new $2 billion open-ended share repurchase program. The buyback plan follows a recent refresh of the company’s priorities and capital approach. The program adds a new capital return lever alongside existing efforts to refine the business mix. Ally Financial enters this move with its shares at $40.51 and a mixed performance profile, including a 14.7% gain over the past year and a 49.7% return over three years. Returns over the past month and year to date...

If you are wondering whether DuPont de Nemours shares still offer value at around US$51.07, it helps to step back and look at what the current price might be implying about the business. The stock has returned 0.4% over the last 7 days, 15.7% over the past month, 25.0% year to date and 52.3% over the past year, with longer term returns of 76.8% over 3 years and 83.4% over 5 years. Recent news around DuPont has focused on the company's portfolio positioning and its place in the broader...

Domino’s Pizza (DPZ) has wrapped up FY 2025 with fourth quarter revenue of US$1.5b and basic EPS of US$5.35, setting the tone for a year where trailing twelve month revenue came in at about US$4.9b and EPS reached US$17.69. Over recent quarters, revenue has ranged from US$1.1b to US$1.5b while quarterly EPS has moved between roughly US$3.84 and US$5.35. This gives investors a clear read on how sales and earnings are tracking into the current share price of US$414.20. With trailing net margins...

In February 2026, Lazard, Inc. added John Koski and Rob Lowe as Managing Directors in its New York Healthcare Group, bringing experience across payors, providers, distributors, and healthcare–technology transactions from roles at Allen & Co. and Citi. Around the same time, Lazard reported quarterly results with revenue growth but pressure on margins and earnings, prompting investors to weigh expansion efforts against profitability trends and insider share sales. Next, we’ll examine how...

If you are wondering whether PACCAR's current share price reflects its underlying worth, this article walks through the key numbers that matter for valuation. PACCAR's stock recently closed at US$126.25, with returns of 3.5% over the past 30 days, 13.2% year to date, and 21.5% over the last year. The 7 day return sits at a 0.2% decline and the 3 year and 5 year returns are 95.3% and 142.0% respectively. Recent news around PACCAR has focused on its position as a major commercial vehicle...

Keurig Dr Pepper (KDP) has wrapped up FY 2025 with fourth quarter revenue of US$4.5 billion and basic EPS of US$0.26, setting the tone for how investors assess the full year. The company has seen quarterly revenue move from US$4.1 billion in Q4 2024 to US$4.5 billion in Q4 2025, while quarterly EPS shifted from a loss of US$0.11 to EPS of US$0.26 over the same period, against a trailing twelve month EPS of US$1.53. With trailing net margin at 12.5% and earnings growth highlighted over the...

In February 2026, Gentherm reported fourth‑quarter 2025 earnings showing net income falling to US$2.99 million from US$15.32 million a year earlier, while quarterly revenue of about US$382.79 million came in ahead of expectations. Alongside weaker profitability, Gentherm issued product revenue guidance of US$1.5 billion to US$1.6 billion for 2026 and US$1.7 billion for 2027, highlighting its ambition to grow beyond automotive into medical and other precision thermal applications. We’ll now...

DigitalOcean Holdings FY 2025 Earnings Snapshot DigitalOcean Holdings (DOCN) has wrapped up FY 2025 with Q4 revenue of US$242.4 million and basic EPS of US$0.28, capping off a year in which trailing twelve month revenue reached US$901.4 million and EPS came in at US$2.83. The company has seen revenue move from US$780.6 million to US$901.4 million on a trailing twelve month basis, while EPS shifted from US$0.92 to US$2.83, with reported earnings growth helped by a very large year over year...

If you are wondering whether Bruker is priced attractively right now, you are not alone, especially with sentiment around the stock shifting recently. The share price closed at US$39.77, with a 4.3% gain over the last 7 days, set against returns of a 21.0% decline over 30 days, a 17.3% decline year to date, and a 21.6% decline over 1 year, as well as 41.7% and 35.1% declines over 3 and 5 years respectively. These mixed shorter term and longer term returns have put more attention on what...

If you are wondering whether TG Therapeutics at around US$30.51 is priced attractively or already baking in a lot of optimism, you are in the right place. The stock has returned 5.0% over the last 7 days, is down 2.2% over 30 days, and shows mixed longer term results with a 4.2% return year to date, 4.5% over 1 year, 90.4% over 3 years, and a 32.0% decline over 5 years. These moves sit against a backdrop of ongoing interest in TG Therapeutics as a biotechnology name, with investors watching...

Twist Bioscience, NasdaqGS:TWST, has entered a co exclusive licensing agreement with Invenra Inc. for Invenra's B Body bispecific antibody platform. The deal expands Twist's antibody discovery services and includes an equity investment and licensing terms that share economics between the two companies. This move adds bispecific antibody capabilities to Twist's existing biologics discovery tools, broadening the range of programs it can support for biotech and pharma customers. Twist...

If you are trying to work out whether Caris Life Sciences at around US$18.20 is a bargain or a value trap, you are in the right place. The stock has been under pressure recently, with a 12.5% decline over the last 7 days, a 27.2% decline over the last 30 days, and a 32.5% decline year to date. Recent attention around Caris Life Sciences has focused on its position in the pharmaceuticals and biotech space and how investors are reassessing risk in the sector. This backdrop helps explain why...

If you are wondering whether Danaos is still good value after its recent run, you are in the right place. This article focuses squarely on what you are paying for each dollar of the business. The stock last closed at US$111.57, with returns of 4.0% over 7 days, 10.8% over 30 days, 17.1% year to date, 41.5% over 1 year and 116.4% over 3 years. These figures naturally raise questions about how much upside or risk is now priced in. Recent coverage of Danaos has highlighted its role in the...